Literature DB >> 21584680

New insights into the translocation route of enrofloxacin and its metalloantibiotics.

C Ribeiro1, S C Lopes, P Gameiro.   

Abstract

Probing drug/lipid interactions at the molecular level represents an important challenge in pharmaceutical research, drug discovery and membrane biophysics. Previous studies showed that enrofloxacin metalloantibiotic has potential as an antimicrobial agent candidate, since it exhibits antimicrobial effect comparable to that of free enrofloxacin but a different translocation route. These differences in uptake mechanism can be paramount in counteracting bacterial resistance. In view of lipids role in bacterial drug uptake, the interaction of these compounds with different Escherichia coli model membranes were studied by fluorescence spectroscopy. Partition coefficients determined showed that lipid/antibiotic interactions were sensitive to liposomes composition and that the metalloantibiotic had a higher partition than free enrofloxacin. These results corroborate the different mechanism of entry proposed and can be rationalized on the basis that an electrostatic interaction between the metalloantibiotic positively charged species, present at physiological pH, and the lipids negatively charged head groups clearly promotes the lipid/antimicrobial association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584680     DOI: 10.1007/s00232-011-9368-4

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  48 in total

Review 1.  Amphipathic, alpha-helical antimicrobial peptides.

Authors:  A Tossi; L Sandri; A Giangaspero
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

2.  Solvatochromic effects in the electronic absorption and nuclear magnetic resonance spectra of hypericin in organic solvents and in lipid bilayers.

Authors:  H Weitman; M Roslaniec; A A Frimer; M Afri; D Freeman; Y Mazur; B Ehrenberg
Journal:  Photochem Photobiol       Date:  2001-02       Impact factor: 3.421

3.  Cardiolipin, a key component to mimic the E. coli bacterial membrane in model systems revealed by dynamic light scattering and steady-state fluorescence anisotropy.

Authors:  S Lopes; C S Neves; P Eaton; P Gameiro
Journal:  Anal Bioanal Chem       Date:  2010-08-01       Impact factor: 4.142

Review 4.  Dissociation and complexation of the fluoroquinolone antimicrobials--an update.

Authors:  D L Ross; C M Riley
Journal:  J Pharm Biomed Anal       Date:  1994-10       Impact factor: 3.935

5.  Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.

Authors:  C Seral; M Barcia-Macay; M P Mingeot-Leclercq; P M Tulkens; F Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

6.  Spectroscopic properties of various quinolone antibiotics in aqueous-organic solvent mixtures.

Authors:  Hyoung-Ryun Park; Chu-Ha Oh; Hyeong-Chul Lee; Sam Ryong Lim; Kiyull Yang; Ki-Min Bark
Journal:  Photochem Photobiol       Date:  2004 Nov-Dec       Impact factor: 3.421

7.  Filipin orientation revealed by linear dichroism. Implication for a model of action.

Authors:  Sílvia C D N Lopes; Erik Goormaghtigh; Benedito J Costa Cabral; Miguel A R B Castanho
Journal:  J Am Chem Soc       Date:  2004-05-05       Impact factor: 15.419

8.  Role of excited state intramolecular charge transfer in the photophysical properties of norfloxacin and its derivatives.

Authors:  M Consuelo Cuquerella; Miguel A Miranda; Francisco Bosca
Journal:  J Phys Chem A       Date:  2006-03-02       Impact factor: 2.781

9.  Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes?

Authors:  Ahmad Arouri; Margitta Dathe; Alfred Blume
Journal:  Biochim Biophys Acta       Date:  2008-12-11

10.  Distinct behaviour of the homeodomain derived cell penetrating peptide penetratin in interaction with different phospholipids.

Authors:  Ofelia Maniti; Isabel Alves; Germain Trugnan; Jesus Ayala-Sanmartin
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

View more
  6 in total

1.  Ciprofloxacin metalloantibiotic: an effective antibiotic with an influx route strongly dependent on lipid interaction?

Authors:  Mariana Ferreira; Paula Gameiro
Journal:  J Membr Biol       Date:  2014-11-07       Impact factor: 1.843

2.  Modulation of enrofloxacin binding in OmpF by Mg2+ as revealed by the analysis of fast flickering single-porin current.

Authors:  Annemarie Brauser; Indra Schroeder; Thomas Gutsmann; Cristian Cosentino; Anna Moroni; Ulf-Peter Hansen; Mathias Winterhalter
Journal:  J Gen Physiol       Date:  2012-06-11       Impact factor: 4.086

3.  Fluoroquinolone Metalloantibiotics: A Promising Approach against Methicillin-Resistant Staphylococcus aureus.

Authors:  Mariana Ferreira; Lucinda J Bessa; Carla F Sousa; Peter Eaton; Dafne Bongiorno; Stefania Stefani; Floriana Campanile; Paula Gameiro
Journal:  Int J Environ Res Public Health       Date:  2020-04-30       Impact factor: 3.390

4.  Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin.

Authors:  Chao Li; Kaixiang Zhou; Dongmei Chen; Wei Xu; Yanfei Tao; Yuanhu Pan; Kuiyu Meng; Muhammad Abu Bakr Shabbir; Qianying Liu; Lingli Huang; Shuyu Xie
Journal:  Int J Nanomedicine       Date:  2019-03-01

5.  Fluoroquinolone Metalloantibiotics to Bypass Antimicrobial Resistance Mechanisms: Decreased Permeation through Porins.

Authors:  Mariana Ferreira; Carla F Sousa; Paula Gameiro
Journal:  Membranes (Basel)       Date:  2020-12-22

Review 6.  Sorption of hydrophobic organic compounds on natural sorbents and organoclays from aqueous and non-aqueous solutions: a mini-review.

Authors:  Francis Moyo; Roman Tandlich; Brendan S Wilhelmi; Stefan Balaz
Journal:  Int J Environ Res Public Health       Date:  2014-05-09       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.